Tesaro stock rockets as rumours of Roche takeover abound
NICE consulting on first draft decision
Roche to join ADMET conference this July in London
The FDA has approved Genentech’s Rituxan (rituximab) for use in adults with moderate-to-severe pemphigus vulgaris (PV), making it the first treatment for the condition in more than 60 years.
Roche has announced that its phase 3 IMpower130 study met its co-primary endpoints of overall survival and progression-free survival in non-small cell lung cancer (NSCLC).
Pre-Filled Syringes and Pharmaceutical Microbiology